News

News-Medical
news-medical. net-medical. net

Novel catalytic approach accelerates synthesis of branched drug compounds

1+ hour, 10+ min ago  (888+ words) News-Medical Novel catalytic approach accelerates synthesis of branched drug compounds When chemists design drug candidates, shape matters enormously. Many active pharmaceutical ingredients contain branched carbon structures-points where the molecular chain forks in a specific direction-that are critical to whether a…...

Bitget
bitget. com > amp > news > detail > 12560605353155

Rallybio Investors Confront Significant Dilution in Merger as $47. 5 M Valuation Marks Major Downturn from Earlier Projections

6+ hour, 37+ min ago  (645+ words) Bitget Rallybio Investors Confront Significant Dilution in Merger as $47. 5 M Valuation Marks Major Downturn from Earlier Projections Analyzing Recent Buyout Structures and Their Impact The mechanics behind the latest buyouts have created a notable gap between expectations and reality. Whether…...

Toronto Star
thestar. com > globenewswire > bdc-launches-a-150-million-life-sciences-venture-fund > article_f4a2db54-8584-5574-b655-6554381c041f. html

BDC launches a $150million Life Sciences Venture Fund

18+ hour, 36+ min ago  (166+ words) MONTREAL, April 09, 2026 (GLOBE NEWSWIRE) " The Business Development Bank of Canada (BDC) today announced the launch of its $150million'Life Sciences Venture Fund, created to support the next generation of Canadian companies in the sector. With this new Fund, BDC is aiming…...

National Today
nationaltoday. com > us > tn > chattanooga > news > 04/09/2026 > novonix-secures-103m-in-tax-credits-for-tennessee-graphite-facility

NOVONIX Secures $103 M in Tax Credits for Tennessee Graphite Facility - Chattanooga Today

3+ hour, 3+ min ago  (412+ words) The U. S. government certification affirms NOVONIX's role in building a domestic battery materials supply chain. Apr. 9, 2026 at 11: 15pm The tax credits will help NOVONIX scale its U. S. manufacturing footprint and deliver a reliable, domestic supply of high-performance synthetic graphite to meet growing demand…...

Stocks To Trade
stockstotrade. com > news > iovance-biotherapeutics-inc-iova-news-2026_04_09

Iovance's Landmark FDA Approval Shakes Up Melanoma Treatment Market

8+ hour, 31+ min ago  (209+ words) Iovance Biotherapeutics Inc. s stocks have been trading up by 9. 51 percent following promising FDA designations boosting investor confidence. Investors have been cautiously optimistic, watching the unfolding events with an eye for gains. Stock price movements point to a tug-of-war between…...

The Standard 英文虎報
thestandard. com. hk > innovation > article > 328874 > HKSTP-leads-five-high-potential-biotech-startups-to-explore-global-collaboration-and-financing-at-premier-biopharma-summit-in-Seoul

HKSTP leads five high-potential biotech startups to explore global collaboration and financing at premier biopharma summit in Seoul

1+ hour, 36+ min ago  (627+ words) As life and health technologies gain attention around the world, cross-regional R&D collaboration and capital matching have become core engines to drive innovation. Hong Kong Science and Technology Parks Corporation (HKSTP) recently led a delegation of five high-potential park…...

scanx. trade
scanx. trade > stock-market-news > companies > advanced-enzyme-technologies-senior-vp-marketing-dipak-roda-resigns > 37311907

Advanced Enzyme Technologies Senior VP Marketing Dipak Roda Resigns

2+ hour, 11+ min ago  (554+ words) Advanced enzyme tech has announced a senior management change with the resignation of Mr. Dipak Roda from his position as Senior Vice President - Marketing and Business Development. The resignation becomes effective from the close of business hours on April 09, 2026. The…...

The Manila Times
manilatimes. net > 04/10/2026 > tmt-newswire > pr-newswire > ailux-appoints-maria-belvisi-phd-as-chief-scientific-officer > 2317759

Ailux Appoints Maria Belvisi, Ph. D. , as Chief Scientific Officer

1+ hour, 49+ min ago  (721+ words) **media[1007894]**Professor Belvisi joins from Astra Zeneca, where she served as Senior Vice President, Research & Development, Respiratory & Immunology and built one of the most productive early R&D organizations in global pharma, including leading tozorakimab from preclinical research through Phase…...

@lelezard
lelezard. com > en > news-22180572. html

Synthetic Biology Market Analysis 2026-2031: Genome Engineering Accounts for 33. 21% Share, with Asia-Pacific as the Fastest-Growing Region, Says Mordor Intelligence

8+ hour, 45+ min ago  (261+ words) Synthetic Biology Market Share by Region North America represents a significant share of the synthetic biology market, driven by strong research funding, advanced biotechnology infrastructure, and the presence of leading industry players. The region continues to lead in innovation and…...

Quartz
qz. com > does-cobenfy-have-the-potential-to-become-a-top-drug-for-bmy

Does Cobenfy Have the Potential to Become a Top Drug for BMY?

2+ hour, 12+ min ago  (539+ words) Bristol Myers" BMY schizophrenia drug Cobenfy delivered a sound performance in 2025. Cobenfy (xanomeline and trospium chloride), formerly Kar XT, is an oral medication. It represents the first new pharmacological approach to treat schizophrenia in decades. The FDA approved the drug…...